Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1089/scd.2020.0198 http://scihub22266oqcxt.onion/10.1089/scd.2020.0198 33715385!ä!33715385 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Stem+Cells+Dev 2021 ; 30 (9): 459-472 Nephropedia Template TP {{tp|p=33715385|t=2021. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19 |pdf=|usr=}}{{33715385}} gab.com Text Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19 JO: Stem Cells Dev http://www.kidney.de/pget.php?&tw=1&pmid=33715385 #FOAvip Corona virus disease 2019 (COVID-19) refers to a type of pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Sixty million confirmed cases have been reported worldwide until November 29, 2020. Unfortunately, the novel coronavirus is extremely contagious and the mortality rate of severe and critically ill patients is high. Thus, there is no definite and effective treatment in clinical practice except for antiviral therapy and supportive therapy. Mesenchymal stem cells (MSCs) are not only characterized by low immunogenicity and homing but also have anti-inflammatory and immunomodulation characteristics. Furthermore, they can inhibit the occurrence and development of a cytokine storm, inhibit lung injury, and exert antipulmonary fibrosis and antioxidative stress, therefore MSC therapy is expected to become one of the effective therapies to treat severe COVID-19. This article will review the possible mechanisms of MSCs in the treatment of severe COVID-19. Twit Text FOAVip Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19 ????Stem Cells Dev http://www.kidney.de/pget.php?&tw=1&pmid=33715385 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33715385 #FOAvip English Wikipedia <ref>{{Cite pmid|33715385}}</ref> Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19 #MMPMID33715385 Cai Q; Yin F; Hao L; Jiang W Stem Cells Dev 2021[May]; 30 (9): 459-472 PMID33715385show ga Corona virus disease 2019 (COVID-19) refers to a type of pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Sixty million confirmed cases have been reported worldwide until November 29, 2020. Unfortunately, the novel coronavirus is extremely contagious and the mortality rate of severe and critically ill patients is high. Thus, there is no definite and effective treatment in clinical practice except for antiviral therapy and supportive therapy. Mesenchymal stem cells (MSCs) are not only characterized by low immunogenicity and homing but also have anti-inflammatory and immunomodulation characteristics. Furthermore, they can inhibit the occurrence and development of a cytokine storm, inhibit lung injury, and exert antipulmonary fibrosis and antioxidative stress, therefore MSC therapy is expected to become one of the effective therapies to treat severe COVID-19. This article will review the possible mechanisms of MSCs in the treatment of severe COVID-19. |Anti-Inflammatory Agents/therapeutic use[MESH] |Antioxidants/therapeutic use[MESH] |COVID-19/*therapy[MESH] |Cytokine Release Syndrome/*prevention & control[MESH] |Humans[MESH] |Immunomodulation/immunology[MESH] |Lung Injury/*prevention & control[MESH] |Mesenchymal Stem Cell Transplantation/*methods[MESH] |Mesenchymal Stem Cells/cytology[MESH] |Oxidative Stress[MESH] |Pulmonary Fibrosis/*prevention & control[MESH]Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19(epmc).pdf DeepDyve Pubget Overpricing